Literature DB >> 31272993

Acute splenic infarction presenting as an unusual manifestation of essential thrombocythaemia with normal platelet count.

Katsuyuki Yoshida1, Ibuki Kurihara1, Takahiko Fukuchi1, Hitoshi Sugawara1.   

Abstract

Essential thrombocythaemia (ET) is characterised by elevated platelet count by a clonal stem cell disorder of megakaryocytes. Although thrombosis is a common complication of ET, splenic infarction (SI) is extremely rare. Here, we present the case of a 31-year-old Japanese man who presented with sudden-onset severe pain at the left hypochondrium on the day before admission. Enhanced abdominal CT revealed SI. The laboratory test results revealed a normal platelet count (439×109/L). Subsequently, the patient was diagnosed with ET because the platelet count gradually increased to 50.0×104/μL, and JAK2 V617F mutation was identified. Accordingly, low-dose aspirin was initiated, and no thrombotic episode occurred. Nevertheless, 6 months postdischarge, the platelet count gradually increased to >650 × 109/L, and anagrelide was initiated. This case demonstrates an unusual complication of acute SI due to ET under the rare situation of the normal platelet count. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  general practice / family medicine; haematology (incl blood transfusion)

Mesh:

Year:  2019        PMID: 31272993      PMCID: PMC6613970          DOI: 10.1136/bcr-2019-229387

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  23 in total

1.  The bedside assessment of splenic enlargement.

Authors:  A N Barkun; M Camus; L Green; T Meagher; L Coupal; J De Stempel; S A Grover
Journal:  Am J Med       Date:  1991-11       Impact factor: 4.965

2.  [A case of essential thrombocythemia associated with splenic infarction].

Authors:  S Aoyama; H Makino; Y Terada; E Takazakura
Journal:  Nihon Naika Gakkai Zasshi       Date:  1988-03

3.  Splenic septic emboli in endocarditis.

Authors:  W Ting; N A Silverman; D A Arzouman; S Levitsky
Journal:  Circulation       Date:  1990-11       Impact factor: 29.690

4.  Splenic infarct presenting as acute abdominal pain in an older patient.

Authors:  M S Beeson
Journal:  J Emerg Med       Date:  1996 May-Jun       Impact factor: 1.484

5.  A case of essential thrombocythemia presenting with aortic thrombosis.

Authors:  Masayuki Oki; Makiko Moriuchi; Hiroshi Kawada; Yoshiaki Ogawa; Kiyoshi Ando
Journal:  Tokai J Exp Clin Med       Date:  2008-12-20

6.  Calreticulin variant stratified driver mutational status and prognosis in essential thrombocythemia.

Authors:  Yoseph C Elala; Terra L Lasho; Naseema Gangat; Christy Finke; Daniela Barraco; Mahnur Haider; Ahmed K Abou Hussein; Curtis A Hanson; Rhett P Ketterling; Animesh Pardanani; Ayalew Tefferi
Journal:  Am J Hematol       Date:  2016-04-04       Impact factor: 10.047

7.  Somatic mutations of calreticulin in myeloproliferative neoplasms.

Authors:  Thorsten Klampfl; Heinz Gisslinger; Ashot S Harutyunyan; Harini Nivarthi; Elisa Rumi; Jelena D Milosevic; Nicole C C Them; Tiina Berg; Bettina Gisslinger; Daniela Pietra; Doris Chen; Gregory I Vladimer; Klaudia Bagienski; Chiara Milanesi; Ilaria Carola Casetti; Emanuela Sant'Antonio; Virginia Ferretti; Chiara Elena; Fiorella Schischlik; Ciara Cleary; Melanie Six; Martin Schalling; Andreas Schönegger; Christoph Bock; Luca Malcovati; Cristiana Pascutto; Giulio Superti-Furga; Mario Cazzola; Robert Kralovics
Journal:  N Engl J Med       Date:  2013-12-10       Impact factor: 91.245

8.  Platelet turnover, coagulation factors, and soluble markers of platelet and endothelial activation in essential thrombocythemia: relationship with thrombosis occurrence and JAK2 V617F allele burden.

Authors:  Eduardo Arellano-Rodrigo; Alberto Alvarez-Larrán; Juan-Carlos Reverter; Dolors Colomer; Neus Villamor; Beatriz Bellosillo; Francisco Cervantes
Journal:  Am J Hematol       Date:  2009-02       Impact factor: 10.047

9.  Outcome of patients with splanchnic venous thrombosis presenting without overt MPN: a role for the JAK2 V617F mutation re-evaluation.

Authors:  Donatella Colaizzo; Lucio Amitrano; Maria Anna Guardascione; Giovanni Luca Tiscia; Giovanna D'Andrea; Vittoria A C Longo; Elvira Grandone; Maurizio Margaglione
Journal:  Thromb Res       Date:  2013-08-01       Impact factor: 3.944

Review 10.  The JAK2 V617F mutation and thrombosis.

Authors:  S K Austin; J R Lambert
Journal:  Br J Haematol       Date:  2008-11       Impact factor: 6.998

View more
  1 in total

1.  Splenic Infarct as the Presenting Manifestation of Essential Thrombocythemia.

Authors:  Shalaka Khade; Sudeep Khera; Vaibhav Kumar Varshney; Deepak Kumar Sharma; Raghav Nayar; Abhishek Purohit
Journal:  Ochsner J       Date:  2022
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.